There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Related collections

Data availability:

Comments

Comment on this article

Cited by 1

Upadacitinib versus placebo or adalimumab with background methotrexate in patients with rheumatoid arthritis and an inadequate response to methotrexate: a subgroup analysis of a phase III randomized controlled trial in Central and Eastern European patients
Authors: Karel Pavelka, Zoltán Szekanecz, Nemanja Damjanov …

See all cited by

Rinvoq (upadacitinib) [package insert]

Read this article at

Related collections

ScienceOpen Research

Comments

Comment on this article

Similar content 1,028

Cited by 1